Co-Authors
This is a "connection" page, showing publications co-authored by MARIA MONICA GRAMATGES and PHILIP LUPO.
Connection Strength
3.019
-
Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS). Cancer Epidemiol Biomarkers Prev. 2019 02; 28(2):417-419.
Score: 0.581
-
A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children's Oncology Group. BMC Cancer. 2025 Oct 20; 25(1):1611.
Score: 0.235
-
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO Precis Oncol. 2022 12; 6:e2200239.
Score: 0.193
-
A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica. 2022 05 01; 107(5):1185-1188.
Score: 0.185
-
Sensor-Based Frailty Assessment in Survivors of Childhood Cancer: A Pilot Study. J Frailty Aging. 2021; 10(2):176-181.
Score: 0.169
-
The relationship between chronic health conditions and cognitive deficits in children, adolescents, and young adults with down syndrome: A systematic review. PLoS One. 2020; 15(9):e0239040.
Score: 0.165
-
Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study. PLoS One. 2020; 15(2):e0228887.
Score: 0.159
-
Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment. Cancer. 2019 10 15; 125(20):3623-3630.
Score: 0.152
-
DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Genes Chromosomes Cancer. 2019 01; 58(1):52-59.
Score: 0.146
-
Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Pediatr Blood Cancer. 2017 Sep; 64(9).
Score: 0.129
-
Admixture Mapping Reveals Candidate Regions for Methotrexate Neurotoxicity Susceptibility: A Reducing Disparities in Acute Leukemia Consortium Report. Pediatr Blood Cancer. 2026 Oct; 73(10):e70554.
Score: 0.062
-
Hyperleukocytosis and outcomes in pediatric B-cell acute lymphoblastic leukemia: A report from the REDIAL Consortium. medRxiv. 2026 Jun 19.
Score: 0.062
-
SMARCAL1 is a new osteosarcoma predisposition gene. J Natl Cancer Inst. 2026 Jun 01; 118(6):1120-1125.
Score: 0.061
-
Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium. Pediatr Blood Cancer. 2026 Jul; 73(7):e70387.
Score: 0.061
-
Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report. Cancer Epidemiol Biomarkers Prev. 2026 May 01; 35(5):710-717.
Score: 0.061
-
Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia. Support Care Cancer. 2026 Feb 17; 34(3):209.
Score: 0.060
-
An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy. Blood Adv. 2025 Nov 25; 9(22):5802-5810.
Score: 0.059
-
Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. Oncologist. 2025 Jun 04; 30(6).
Score: 0.057
-
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 01; 45(1):4-11.
Score: 0.056
-
Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer. J Clin Oncol. 2024 07 01; 42(19):2306-2316.
Score: 0.053
-
Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Cancer. 2023 04 15; 129(8):1276-1286.
Score: 0.049
-
Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate. Cancer. 2023 04 15; 129(8):1287-1294.
Score: 0.049
-
Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2022 12; 63(12):2948-2954.
Score: 0.047
-
Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor. Pediatr Hematol Oncol. 2023 May; 40(4):407-411.
Score: 0.047
-
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Lancet Haematol. 2022 Sep; 9(9):e678-e688.
Score: 0.047
-
Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2020 01 20; 38(3):232-247.
Score: 0.039
-
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
Score: 0.035